drugset / Trial / NCT06711146
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
NaSequentialOpen-labelTreatment
Summary
A Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Moderate to Severe Active Systemic Lupus Erythematosus
Timeline
- Start
- 2024-12-24
- Primary completion
- 2026-12-01
- Completion
- 2027-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metabolically Armed CD19 CAR-T cells | Cell therapy | — | Intravenous |